RWJBarnabas Health, Rutgers open $225M cancer center
Elizabeth Gregerson / beckershospitalreview - On June 22, West Orange, N.J.-based RWJBarnabas Health and New Brunswick, N.J.-based Rutgers Cancer Institute opened the Melchiorre Cancer Center at Cooperman Barnabas Medical Center in Livingston, N.J. The cancer center cost $225 million, according to a …
AI Summary: Results presented at ASCO for daraxonrasib delivered practice‑changing evidence in pancreatic cancer, prompting clinicians to offer the drug off‑trial within weeks. The data generated excitement across conferences and clinical teams, fueling early adoption discussions and raising hopes for a tangible advance against a historically stubborn disease.
- ASCO shockwave: Daraxonrasib survival curve draws standing ovation (3)
- Competing KRAS strategies: zoldonrasib, HRS‑4642 and blood testing (4)
- Conference context: RAS momentum and expert reflections (5)
- Rapid off‑trial rollout and early patient access (4)
- All Other Stories
ASCO shockwave: Daraxonrasib survival curve draws standing ovation
Competing KRAS strategies: zoldonrasib, HRS‑4642 and blood testing
Conference context: RAS momentum and expert reflections
Rapid off‑trial rollout and early patient access
All Other Stories
AI system detects sudden cardiac death risk, identifying thousands more patients annually
medicalxpress - Each year in the U.S., more than 300,000 people die from sudden cardiac arrest, a condition in which the heart's electrical system malfunctions without warning. The medical emergency can kill both high-risk older adults and young athletes with no history …
AI Summary: New AI tools claim to identify far more patients at risk of sudden cardiac death than traditional metrics, detecting subtle patterns invisible to clinicians. Early studies suggest strong sensitivity gains, but experts caution that screening scale‑up, false positives and prospective validation will determine whether the tech saves lives or simply creates more testing.
FDA Approves Gilead’s Trodelvy, Alone and With Merck’s Keytruda, in First-Line Metastatic TNBC
oncodaily - Decision delivers the first ADC-based regimens for previously untreated triple-negative breast cancer across PD-L1 status, a PD-L1-positive Keytruda combination plus a monotherapy option for immunotherapy-ineligible patients. The U.S. Food and […]
AI Summary: The FDA approved sacituzumab govitecan (Trodelvy) as both monotherapy and in combination with pembrolizumab (Keytruda) for first-line treatment of metastatic triple‑negative breast cancer, expanding options for a hard-to-treat population. Regulators cited clinical benefit in appropriate patients, reshaping treatment sequencing and payer discussions.
A Ban Won’t Stop Abortion Pill Access, Telehealth Providers Say
Kate Wells / kffhealthnews - As a federal court mulls a case that could result in significant restrictions on a pill used in most abortions, providers say they have alternatives to preserve access even in states with bans in place.
AI Summary: Providers and telehealth advocates warn that banning access won’t stop patients from obtaining abortion pills online. Telemedicine and pharmacy workarounds continue to provide routes for care, underscoring limits of state bans and foreshadowing prolonged legal and practical battles over remote prescribing, cross‑border services, and patient privacy.
As PBM industry shifts, LucyRx and Abarca Health merge to build scale
fiercehealthcare - Amid significant shifts in the pharmacy benefit management industry, LucyRx and Abarca Health have revealed plans to merge to build the scale necessary to compete in this changing landscape.
AI Summary: Two independent pharmacy benefit managers, LucyRx and Abarca Health, announced a combination to build scale amid industry consolidation. The deal aims to bolster negotiating leverage, broaden client reach and offer an alternative to dominant PBMs—because apparently one disruptor wasn’t enough to disrupt the disruptors.
FDA Approves Datopotamab Deruxtecan-dlnk for Unresectable or Metastatic TNBC
esmo -
AI Summary: Regulators have approved datopotamab deruxtecan for patients with unresectable or metastatic triple‑negative breast cancer, offering a new targeted option where few exist. The decision follows trial evidence of meaningful anti‑tumor activity and expands the treatment toolkit for aggressive TNBC subtypes, with clinicians weighing sequencing and toxicity management.
Ashok Sebastian Komaranchath: Delighted to Speak at the 5th International Oncology Forum on 20–21 June 2026
oncodaily - Ashok Sebastian Komaranchath, Consultant Medical Oncology and Clinical Lead for Oncology Services at Burjeel Cancer Institute, Oman, shared on LinkedIn: “I was delighted to speak at the 5th International Oncology Forum […]
AI Summary: The FDA (and HHS) launched Operation TrialBlazer, an initiative to accelerate and modernize clinical development by streamlining trial design, data sharing and regulatory pathways. The program aims to reclaim trial competitiveness and reduce time‑to‑market, promising faster patient access — if stakeholders can agree on what “modernize” actually means.
Medical Journal Retracts Study Claiming Cancer Therapy Is More Effective When Given in the Morning
Rebecca Robbins / nytimes - In a notice flagging a series of problems with a clinical trial, the journal Nature Medicine said its editors “no longer have confidence in the integrity of the results.”
AI Summary: A high‑profile medical journal retracted a paper that claimed cancer immunotherapy is significantly more effective when administered in the morning. The reversal follows scrutiny over methods and data integrity, prompting clinicians to pause any scheduling changes until robust evidence actually materializes.
Generative AI-enabled clinical decision support system in primary care: a pragmatic, cluster-randomized trial
Ambrose Agweyu / nature - Nature Medicine, Published online: 26 June 2026; doi:10.1038/s41591-026-04503-6A pragmatic cluster-randomized trial found that ChatGPT-4o-assisted decision support in Kenyan primary care facilities did not significantly reduce 14-day treatment failure ove…
AI Summary: A pragmatic, cluster‑randomized trial showed that a generative AI clinical decision support tool improved clinician decision‑making in real‑world primary care settings. The results suggest practical benefits beyond pilot hype, though implementation, safety and privacy challenges remain on the checklist before widescale roll‑out.
Bruce Levine: Ten-Year Outcomes Reinforce the Durability of CD19 CAR T-Cell Therapy
oncodaily - Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy at the University of Pennsylvania, shared a post on X: “NEW – Ten-Year Outcomes after CAR T-Cell Therapy for […]
AI Summary: Long‑term data reveal that CD19 CAR‑T therapy produces durable remissions in a subset of B‑cell lymphoma patients, with ten‑year outcomes reinforcing the treatment's long‑term benefit for some. The findings bolster CAR‑T’s curative potential while underscoring the need to identify who will enjoy durable responses.
Medicare’s AI Push Snarls Patients and Doctors in Errors and Delays
Darius Tahir / kffhealthnews - Medicare is testing the use of artificial intelligence to preapprove several healthcare services. Federal health officials say prior authorization can help reduce fraud and contain costs. But doctors and patients describe the trial as “horrendous” and ful…
AI Summary: Reports show Medicare’s push to deploy AI in administrative and clinical workflows has inadvertently created errors and delays, snaring patients and clinicians in a tangle of misclassifications, coverage denials and technical glitches. The rollout highlights risks of scaling automated decision tools without robust testing, oversight and clear escalation pathways for frontline staff.
- Fixing AI: governance, health systems and nursing oversight (4)
- Medicare AI pilot snarls care with denials and delays (3)
- When AI takes action: autonomous clinical agents create risks (4)
Fixing AI: governance, health systems and nursing oversight
Medicare AI pilot snarls care with denials and delays
When AI takes action: autonomous clinical agents create risks
Democrats to propose bill capping out-of-pocket costs for Medicare enrollees
fiercehealthcare - Sen. Ron Wyden and 14 Democratic co-sponsors plan to introduce legislation Thursday to cap consumers’ potential out-of-pocket costs in traditional Medicare, resurfacing a long-running debate over why the program doesn’t limit beneficiary spending.
AI Summary: Democrats unveiled a legislative proposal to place a ceiling on out‑of‑pocket expenses for Medicare beneficiaries, aiming to reduce financial strain on enrollees facing high medical costs. The plan would limit patient spending on covered services, seek savings across programs, and position lawmakers as stepping in where rising health bills continue to bite.
AACR Report on Cancer Disparities and Health Equity
oncodaily - American Association for Cancer Research (AACR) shared a post on LinkedIn: “The AACR Cancer Disparities Progress Report 2026 is now available. The report outlines the myriad factors that drive and […]
AI Summary: The American Association for Cancer Research released a progress report detailing persistent gaps in cancer outcomes across race, ethnicity, socioeconomic status and geography. It documents uneven access to screening, trials and treatments, calls for targeted funding, workforce diversity and policy fixes, and urges measurable equity goals—because apparently pointing out the problem is step one.
- AACR report release and leadership outreach (4)
- Policy push: briefings, funding calls, and trial equity (4)
AACR report release and leadership outreach
Policy push: briefings, funding calls, and trial equity
Patient messages to providers skyrocket since 2020: study
Emily Olsen / healthcaredive - Between 2020 and 2025, patient-written messages increased 153%, according to the study in JAMA. But office visits also rose, suggesting messaging doesn’t replace in-person care.
AI Summary: New analyses reveal a dramatic surge in patient-to-provider electronic messages since 2020, placing measurable strain on clinician inboxes and workflow. The rise highlights growing demand for digital access to care, mounting clinician workload and the need for better triage, staffing and technology solutions—because apparently silence in the inbox is passé.
Jeremy Clarkson’s Prostate Cancer Story: Early Detection, Treatment, and Remission
oncodaily - Jeremy Clarkson has revealed that he was diagnosed with an aggressive form of prostate cancer that was caught early. The broadcaster shared the diagnosis in the final episodes of Clarkson’s […]
AI Summary: Jeremy Clarkson publicly revealed an aggressive prostate cancer diagnosis, underwent early detection and treatment, and is now in remission. The case highlights the value of prompt screening and modern therapies — and proves even TV personalities can be very boringly human when faced with routine medicine.
US health spending spikes to $5.7T in 2025, though growth should moderate, CMS finds
Rebecca Pifer Parduhn / healthcaredive - Utilization — not cost growth — continues to accelerate spending, government actuaries said. Spiking prescription drug spending, including on GLP-1s, is especially acute.
AI Summary: A new CMS analysis shows U.S. health spending will jump sharply — hitting roughly $5.7 trillion in 2025 — with long‑term projections approaching $9 trillion by 2034. The report attributes growth to demographics, price and service use, while cautioning that growth rates should moderate. Policymakers face the delightful task of paying for care nobody asked to be cheaper.
Senators call for $50B rural health fund to better target small providers, relax spending restrictions
fiercehealthcare - The Centers for Medicare and Medicaid Services has substantial leeway on how funds from the Rural Health Transformation Program are doled out. Lawmakers warn the current approach "may unintentionally disadvantage many of the rural hospitals and clinics th…
AI Summary: Lawmakers and health systems are debating the $50 billion Rural Health Transformation fund: senators urge targeted support and relaxed spending rules for small providers while critics warn the program could incentivize shrinkage and disadvantage independent hospitals. Some states are already moving to allocate initial funds, intensifying the policy fight over rural health strategy.
- Hospitals on brink: closures and turnarounds (3)
- Lawmakers and nonprofits push workforce and surgical access fixes (4)
- Senators warn fund may favor shrinkage, hurt independents (4)
- States and agencies start allocating rural health funds (4)
- All Other Stories
Hospitals on brink: closures and turnarounds
Lawmakers and nonprofits push workforce and surgical access fixes
Senators warn fund may favor shrinkage, hurt independents
States and agencies start allocating rural health funds
All Other Stories
Cadence secures $100M series C to advance AI-powered care for chronic disease
fiercehealthcare - The company plans to use the fresh funding to advance its AI agents, grow in value-based care models and expand across new health systems.
AI Summary: Cadence secured a $100 million financing round to expand its AI‑driven chronic care platform, aiming to automate care workflows and improve long‑term disease management at scale. Investors are backing the bet that software can finally make chronic care less fragmented — and maybe less expensive — if the tech behaves itself.
Indiana takes on powerful hospitals by capping prices they charge employers
medicalxpress - Tired of watching its employers struggle to afford the cost of health care, Republican-controlled Indiana is trying a traditionally liberal tactic to control costs: setting government price controls on hospitals.
AI Summary: Indiana enacted legislation capping the prices hospitals can charge employers, a bold move aimed at reining in dominant health systems that have long driven up commercial costs. The measure forces hospitals to accept lower, more predictable rates for employer-covered care, prompting industry pushback as the state tries to rebalance bargaining power.
DOJ announces $6.5B healthcare fraud takedown with record Medicaid enforcement
fiercehealthcare - Law enforcement unveiled charges against 455 defendants for their alleged participation in healthcare schemes, among which fraudulent amniotic wound allografts and undelivered Medicaid services were spotlighted.
AI Summary: The Department of Justice announced a sweeping $6.5 billion healthcare fraud enforcement action, charging multiple defendants in schemes involving fraudulent billing, shell companies and luxury purchases. The coordinated takedown underscores ongoing federal efforts to police Medicare and Medicaid fraud and recover misspent taxpayer funds.
- Corporate Civil Suits and Settlements in Healthcare Fraud (3)
- Mass DOJ Takedown: 455 Charged in $6.5B Fraud (5)